Breast cancer treatment has evolved significantly over recent decades, offering patients a range of options designed to remove tumors, stop cancer cells from multiplying, and improve the chances of living a long and healthy life. Treatment choices depend on the type of breast cancer, how far it has spread, the presence of certain protein receptors in cancer cells, and each patient’s individual circumstances.

Understanding Breast Cancer Treatment: What to Expect and How Choices Are Made

When someone is diagnosed with breast cancer, one of the first things that may come to mind is uncertainty about what happens next. The good news is that treatment approaches for breast cancer have become more precise and effective over time. Modern medicine recognizes that no two breast cancers are exactly alike. This means that healthcare teams now work to match treatment plans to the specific characteristics of each person’s cancer, their overall health, and their personal preferences.^[1]

The main goals of breast cancer treatment are to remove cancerous tissue from the body, prevent the cancer from spreading to other areas, reduce the risk of the cancer coming back, and manage symptoms to help people maintain the best possible quality of life. For many patients, treatment may involve a combination of different approaches. These might include surgery to physically remove tumors, medications that travel through the bloodstream to kill cancer cells throughout the body, and radiation therapy that uses focused energy to destroy remaining cancer cells in a specific area.^[10]

Doctors determine which treatments to recommend based on several important factors. They look at where the cancer started in the breast tissue, whether it has spread to nearby lymph nodes or other parts of the body, how large the tumor is, and what stage the cancer has reached. Stage refers to how advanced the cancer is, ranging from Stage 0 (very early, non-invasive cancer) to Stage IV (cancer that has spread to distant organs). Healthcare providers also test the cancer cells to see if they have special receptors on their surface. Receptors are protein molecules that can attract hormones like estrogen and progesterone, or a protein called HER2. Knowing whether these receptors are present helps doctors choose treatments that will work best against that particular cancer.^[15]

Treatment decisions are made by a team of specialists who bring different types of expertise. This team often includes a medical oncologist (a doctor who specializes in treating cancer with medications), a surgical oncologist (a surgeon who specializes in removing cancerous tissue), and a radiation oncologist (a doctor who uses radiation to treat cancer). Nurses, social workers, nutritionists, and other healthcare professionals also play vital roles in supporting patients through their treatment journey.^[8]

Standard Treatment Approaches for Breast Cancer

Standard treatment for breast cancer refers to approaches that have been proven effective through extensive research and are widely accepted by medical organizations around the world. These treatments form the backbone of breast cancer care and are tailored to each patient’s specific situation.

Surgery

Surgery is often the first step in treating breast cancer, especially when the cancer has not spread beyond the breast and nearby lymph nodes. The goal of surgery is to remove as much cancerous tissue as possible. There are two main types of surgery for breast cancer. A lumpectomy, also called breast-conserving surgery, removes only the tumor and a small amount of surrounding healthy tissue. This option allows most of the breast to remain intact. A mastectomy removes the entire breast, and sometimes both breasts if the risk to the other breast is high.^[10]

The choice between lumpectomy and mastectomy depends on several factors, including the size of the tumor relative to the size of the breast, whether there are multiple tumors in different areas of the breast, and the patient’s personal preferences. Studies have shown that for many women with early-stage breast cancer, lumpectomy followed by radiation therapy offers survival rates similar to mastectomy. However, mastectomy may be recommended if the tumor is large, if cancer cells are found in multiple areas of the breast, or if the patient prefers to remove the entire breast to reduce the risk of cancer returning.^[13]

During surgery, doctors often check nearby lymph nodes to see if cancer has spread. A procedure called sentinel lymph node biopsy involves removing only a few lymph nodes under the arm to test them for cancer cells. This approach causes fewer side effects than removing many lymph nodes. If cancer is found in the sentinel nodes, additional lymph nodes may need to be removed. Removing lymph nodes can sometimes lead to a condition called lymphedema, where fluid builds up in the arm, causing swelling. Physical therapy and other supportive care can help manage this condition.^[10]

Radiation Therapy

Radiation therapy uses high-energy beams, similar to X-rays, to destroy cancer cells that may remain after surgery. For women who have a lumpectomy, radiation therapy to the breast is typically recommended to reduce the risk of cancer coming back in the same area. The radiation is carefully targeted to avoid harming healthy tissue as much as possible.^[16]

Radiation therapy is usually given five days a week for several weeks. Each treatment session lasts only a few minutes, though the entire appointment may take longer to ensure proper positioning. The radiation itself is painless, but over time it can cause side effects in the treated area. These may include redness, swelling, and tenderness of the skin, similar to a sunburn. Fatigue is also common during radiation treatment. Most of these side effects gradually improve after treatment ends.^[12]

Not everyone who has breast cancer surgery needs radiation therapy. Women who have a mastectomy may or may not need radiation, depending on factors such as the size of the tumor, whether cancer was found in lymph nodes, and how close the tumor was to the chest wall. Healthcare providers carefully weigh the benefits of radiation against potential side effects when making recommendations.^[16]

Chemotherapy

Chemotherapy uses powerful medications to kill cancer cells throughout the body. Unlike surgery and radiation, which treat cancer in a specific location, chemotherapy travels through the bloodstream and can reach cancer cells that may have spread beyond the breast. Chemotherapy may be given before surgery to shrink large tumors, making them easier to remove. This is called neoadjuvant chemotherapy. It can also be given after surgery to destroy any remaining cancer cells and reduce the risk of the cancer returning. This is called adjuvant chemotherapy.^[11]

There are many different chemotherapy drugs, and doctors often use combinations of several drugs together. Common chemotherapy regimens for breast cancer include drugs such as doxorubicin, cyclophosphamide, paclitaxel, and docetaxel. The choice of drugs and the duration of treatment depend on the stage and type of breast cancer. Chemotherapy is typically given in cycles, with a period of treatment followed by a period of rest to allow the body to recover. Treatment may last several months.^[11]

Chemotherapy affects rapidly dividing cells, which includes cancer cells but also some healthy cells, such as those in the hair follicles, digestive system, and bone marrow. This is why chemotherapy can cause side effects such as hair loss, nausea, vomiting, diarrhea, mouth sores, and an increased risk of infection due to low white blood cell counts. Many of these side effects can be managed with medications and supportive care. Most side effects are temporary and improve after treatment ends, though some people may experience long-term effects such as fatigue or nerve damage called peripheral neuropathy, which causes tingling or numbness in the hands and feet.^[20]

Hormone Therapy

Hormone therapy is used to treat breast cancers that have hormone receptors. These cancers, called hormone receptor-positive or HR-positive breast cancers, need hormones like estrogen or progesterone to grow. Hormone therapy works by blocking the body’s natural hormones from reaching cancer cells or by lowering the amount of hormones the body makes. This helps slow or stop the growth of cancer cells.^[11]

One of the most commonly used hormone therapy drugs is tamoxifen. Tamoxifen blocks estrogen receptors on breast cancer cells, preventing estrogen from fueling cancer growth. It can be used in women before and after menopause and is typically taken as a daily pill for five to ten years. Another class of hormone therapy drugs called aromatase inhibitors works by reducing the amount of estrogen the body produces. These drugs, which include letrozole, anastrozole, and exemestane, are used primarily in women who have gone through menopause. They are also taken daily for several years.^[11]

Hormone therapy can cause side effects similar to menopause symptoms, including hot flashes, night sweats, vaginal dryness, and mood changes. Tamoxifen can increase the risk of blood clots and, in rare cases, uterine cancer. Aromatase inhibitors can cause joint pain and stiffness and may lead to bone thinning over time. Despite these potential side effects, hormone therapy has been shown to significantly reduce the risk of breast cancer recurrence and improve survival for women with hormone receptor-positive breast cancer.^[14]

Targeted Therapy

Targeted therapy drugs are designed to attack specific characteristics of cancer cells while causing less harm to normal cells. One important type of targeted therapy is used for breast cancers that have too much of a protein called HER2. About 15 to 20 percent of breast cancers are HER2-positive, meaning they have high levels of this protein, which helps cancer cells grow and divide quickly.^[15]

The most well-known targeted therapy for HER2-positive breast cancer is trastuzumab (brand name Herceptin). Trastuzumab is an antibody that attaches to the HER2 protein on cancer cells and helps stop them from growing. It also helps the immune system recognize and destroy cancer cells. Trastuzumab is given as an infusion into a vein, usually every one to three weeks, and treatment may continue for up to a year. Other HER2-targeted drugs include pertuzumab, which is often given along with trastuzumab, and newer drugs like trastuzumab deruxtecan and trastuzumab emtansine, which combine a HER2-targeted antibody with chemotherapy.^[11]

Targeted therapy has significantly improved outcomes for people with HER2-positive breast cancer. Before these drugs were available, HER2-positive breast cancer was considered more aggressive and harder to treat. Now, survival rates for HER2-positive breast cancer are similar to or even better than other types of breast cancer. Side effects of HER2-targeted therapy can include heart problems, so doctors monitor heart function carefully during treatment. Other side effects may include fever, chills, nausea, and diarrhea.^[11]

Innovative Treatments Being Tested in Clinical Trials

While standard treatments have helped millions of people with breast cancer, researchers continue to develop and test new approaches that may offer even better results. Clinical trials are research studies that test new treatments to see if they are safe and effective. Participating in a clinical trial can give patients access to cutting-edge therapies that are not yet widely available.^[12]

Understanding Clinical Trial Phases

Clinical trials are conducted in phases, each designed to answer specific questions about a new treatment. Phase I trials are the earliest studies in humans and focus on determining whether a new treatment is safe and identifying the best dose. These trials typically involve a small number of people. Phase II trials test whether the new treatment works against a specific type of cancer and continue to evaluate safety. These trials involve more participants than Phase I studies. Phase III trials compare the new treatment to current standard treatments to see if it works better, has fewer side effects, or offers other advantages. These are large studies that may involve hundreds or thousands of people. If a Phase III trial shows that a new treatment is safe and effective, it may be approved by regulatory agencies for general use.^[12]

Immunotherapy

Immunotherapy is one of the most exciting areas of cancer research. Unlike chemotherapy, which directly kills cancer cells, immunotherapy helps the body’s own immune system recognize and attack cancer. One type of immunotherapy being tested for breast cancer uses drugs called checkpoint inhibitors. These drugs work by blocking proteins that prevent immune cells from attacking cancer cells. When these checkpoint proteins are blocked, the immune system can recognize cancer cells as dangerous and destroy them.^[18]

Several checkpoint inhibitors are being studied in breast cancer clinical trials. For example, drugs that target a checkpoint protein called PD-1 or PD-L1 have shown promise, particularly in treating triple-negative breast cancer. Triple-negative breast cancer does not have estrogen, progesterone, or HER2 receptors, which makes it harder to treat because hormone therapy and HER2-targeted therapy do not work. One checkpoint inhibitor called pembrolizumab has been approved for use in combination with chemotherapy for certain patients with triple-negative breast cancer that has spread to other parts of the body.^[18]

Immunotherapy can cause side effects that are different from those of chemotherapy. Because these drugs stimulate the immune system, they can sometimes cause the immune system to attack healthy tissues, leading to inflammation in organs such as the lungs, liver, intestines, or thyroid gland. These side effects, called immune-related adverse events, can be serious but are often manageable if caught early. Researchers continue to study ways to make immunotherapy more effective for more patients with breast cancer.^[18]

Newer Targeted Therapies

Researchers are developing new targeted therapies that attack cancer cells in different ways. One promising class of drugs targets proteins called CDK4/6, which help cancer cells divide and grow. CDK4/6 inhibitors such as palbociclib, ribociclib, and abemaciclib are used in combination with hormone therapy to treat hormone receptor-positive, HER2-negative breast cancer that has spread beyond the breast. Clinical trials have shown that adding a CDK4/6 inhibitor to hormone therapy can help slow cancer growth and extend the time before the cancer gets worse.^[11]

Another area of research involves drugs called PARP inhibitors. PARP is a protein that helps cells repair damaged DNA. Some breast cancers, particularly those in people with inherited mutations in the BRCA1 or BRCA2 genes, have difficulty repairing DNA damage. PARP inhibitors prevent cancer cells from fixing their DNA, which causes them to die. Drugs like olaparib and talazoparib have been approved for treating metastatic breast cancer in people with BRCA mutations, and researchers are studying whether these drugs can help in earlier stages of breast cancer as well.^[11]

Antibody-Drug Conjugates

Antibody-drug conjugates represent an innovative approach that combines the targeting ability of antibodies with the cell-killing power of chemotherapy. These drugs consist of an antibody attached to a chemotherapy molecule. The antibody seeks out cancer cells and delivers the chemotherapy directly to them, reducing harm to healthy cells. One antibody-drug conjugate called sacituzumab govitecan has shown promise in treating triple-negative breast cancer that has spread to other parts of the body. It works by targeting a protein called Trop-2, which is found on the surface of many breast cancer cells. Clinical trials have shown that this drug can help shrink tumors and extend survival in patients whose cancer has progressed after other treatments.^[18]

Gene Therapy and Precision Medicine

Gene therapy aims to treat cancer by introducing genetic material into cells to fight the disease. While this approach is still in early stages of research for breast cancer, it holds promise for the future. Precision medicine involves analyzing the genetic makeup of a person’s tumor to identify specific mutations or changes that might be targeted with particular drugs. By understanding the unique molecular characteristics of each cancer, doctors may be able to choose treatments that are most likely to work for that individual. Clinical trials are testing whether matching treatments to specific genetic changes in tumors can improve outcomes for breast cancer patients.^[18]

Where Clinical Trials Take Place and Who Can Participate

Clinical trials for breast cancer are conducted at cancer centers, hospitals, and research institutions around the world, including in the United States, Europe, and many other regions. To participate in a clinical trial, patients typically need to meet specific criteria, which may include the type and stage of breast cancer, previous treatments received, and overall health status. Healthcare providers can help patients find appropriate clinical trials and determine whether participation might be a good option. Organizations such as the National Cancer Institute provide online databases where patients and doctors can search for active clinical trials.^[9]

Most common treatment methods

• Surgery
  • Lumpectomy removes the tumor and a small amount of surrounding tissue while preserving most of the breast
  • Mastectomy removes the entire breast, and sometimes both breasts
  • Sentinel lymph node biopsy checks nearby lymph nodes for cancer spread
• Radiation therapy
  • Uses high-energy beams to destroy remaining cancer cells after surgery
  • Typically given five days a week for several weeks
  • Recommended after lumpectomy to reduce risk of cancer returning
• Chemotherapy
  • Uses drugs like doxorubicin, cyclophosphamide, paclitaxel, and docetaxel to kill cancer cells
  • Can be given before surgery (neoadjuvant) to shrink tumors or after surgery (adjuvant) to destroy remaining cells
  • Treatment typically lasts several months in cycles
• Hormone therapy
  • Tamoxifen blocks estrogen receptors on cancer cells and can be used before or after menopause
  • Aromatase inhibitors (letrozole, anastrozole, exemestane) reduce estrogen production in postmenopausal women
  • Usually taken daily for five to ten years
• Targeted therapy
  • Trastuzumab (Herceptin) targets HER2-positive breast cancers by blocking HER2 protein
  • Pertuzumab is often combined with trastuzumab for HER2-positive cancers
  • CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib) slow cancer cell division in hormone receptor-positive cancers
  • PARP inhibitors (olaparib, talazoparib) treat breast cancer in people with BRCA gene mutations
• Immunotherapy
  • Checkpoint inhibitors like pembrolizumab help the immune system recognize and attack cancer cells
  • Particularly studied for triple-negative breast cancer
  • Used in combination with chemotherapy in certain advanced breast cancers
• Antibody-drug conjugates
  • Trastuzumab deruxtecan and trastuzumab emtansine combine HER2 targeting with chemotherapy
  • Sacituzumab govitecan targets Trop-2 protein in triple-negative breast cancer
  • Deliver chemotherapy directly to cancer cells while sparing healthy tissue

Managing Side Effects and Maintaining Quality of Life During Treatment

Managing side effects is an important part of breast cancer treatment. Many side effects can be reduced or controlled with medications, lifestyle changes, and supportive care. For example, medications are available to prevent or reduce nausea from chemotherapy, and fatigue may improve with gentle exercise, good sleep habits, and proper nutrition. Healthcare teams include specialists such as nutritionists, physical therapists, and social workers who can provide guidance and support.^[20]

Emotional and psychological support is also crucial. Being diagnosed with and treated for breast cancer can bring feelings of fear, anxiety, sadness, and uncertainty. Talking with a counselor, joining a support group, or connecting with others who have been through similar experiences can help. Many cancer centers offer programs that address the emotional and practical challenges of living with and beyond breast cancer.^[21]

Life After Treatment: Follow-Up Care and Monitoring

After completing active treatment for breast cancer, regular follow-up care is essential. Follow-up appointments allow doctors to monitor for any signs that the cancer has returned and to manage any long-term side effects of treatment. Follow-up care typically includes physical examinations, discussions about symptoms, and periodic mammograms to check for new cancers. The frequency of follow-up visits may be more frequent in the first few years after treatment and then less often over time.^[16]

Survivorship care also focuses on overall health and wellness. This may include recommendations for healthy eating, regular physical activity, maintaining a healthy weight, limiting alcohol, and not smoking. Some people may need ongoing medications, such as hormone therapy, for several years after initial treatment. Managing side effects that persist after treatment, such as fatigue, joint pain, or emotional distress, is also an important part of survivorship care.^[25]

Many cancer centers have survivorship programs that provide coordinated care and resources to help people transition from active treatment to life after cancer. These programs may offer education, support groups, wellness activities, and assistance with practical issues such as returning to work or managing insurance concerns.^[26]